|
ZNF501 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.174400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.204600E-03 |
| Normal-vs-Stage2 |
3.269500E-02 |
| Normal-vs-Stage3 |
3.55320000000603E-05 |
| Normal-vs-Stage4 |
2.05149999998877E-06 |
| Stage1-vs-Stage2 |
5.755600E-01 |
| Stage1-vs-Stage3 |
3.193800E-02 |
| Stage1-vs-Stage4 |
1.779480E-03 |
| Stage2-vs-Stage3 |
3.764400E-01 |
| Stage2-vs-Stage4 |
6.766200E-02 |
| Stage3-vs-Stage4 |
2.367600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.275120E-03 |
| Normal-vs-AfricanAmerican |
1.257250E-03 |
| Normal-vs-Asian |
7.041600E-03 |
| Caucasian-vs-AfricanAmerican |
5.335800E-01 |
| Caucasian-vs-Asian |
4.106400E-01 |
| AfricanAmerican-vs-Asian |
4.978400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.208110E-04 |
| Normal-vs-Female |
7.766100E-02 |
| Male-vs-Female |
2.584400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.005000E-04 |
| Normal-vs-Extreme_Weight |
7.956500E-04 |
| Normal-vs-Obese |
4.874000E-02 |
| Normal-vs-Extreme_Obese |
4.355900E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.797600E-01 |
| Normal_Weight-vs-Obese |
1.556020E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.129800E-01 |
| Extreme_Weight-vs-Obese |
3.224800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.387600E-01 |
| Obese-vs-Extreme_Obese |
6.091600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.862900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.516400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.25839999999922E-05 |
| Normal-vs-Age(81-100Yrs) |
1.067610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.003400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.406400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.212600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.750030E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.383600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.523400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.084000E-02 |
| Normal-VS-Type2 PRCC |
4.0101000298165E-10 |
| Normal-VS-KIRP CIMP |
1.08409947685573E-11 |
| Normal-VS-Unclassified PRCC |
6.501800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.77059999573981E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.55229948287194E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
3.807200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.768600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.829900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.12910000027844E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6904999999845E-06 |
| Normal-vs-N1 |
4.233900E-04 |
| Normal-vs-N2 |
1.351440E-04 |
| N0-vs-N1 |
5.832000E-01 |
| N0-vs-N2 |
1.271200E-01 |
| N1-vs-N2 |
3.678200E-01 |
|
|
